← SynDRA
TW-37
SynDRA canonical compound SYN1947976 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | BCL2 | BCL2L1 | MCL1 |
| Mechanism of action | BCL inhibitor |
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- tw 37
- N-[4-(2-tert-Butylphenylsulfonyl)phenyl]-2,3,4-trihydroxy-5-(2-isopropylbenzyl)benzamide
- CHEMBL217354
- N-(4-((2-(tert-butyl)phenyl)sulfonyl)phenyl)-2,3,4-trihydroxy-5-(2-isopropylbenzyl)benzamide
- N-(4-(2-tert-butylphenylsulfonyl)phenyl)-2,3,4-trihydroxy-5-(2-isopropylbenzyl)benzamide
- N-[4-[(2-tert-Butylphenyl)sulfonyl]phenyl]-2,3,4-trihydroxy-5-[(2-isopropylphenyl)methyl]benzamide
- N-(4-((2-Tert-Butylphenyl)sulfonyl)phenyl)-2,3,4-trihydroxy-5-((2-isopropylphenyl)methyl)benzamide
Look up TW-37 in the interactive SynDRA portal →